Insider · CIK 0001748808

Otto Dawn Parsell

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001748808

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-28	Tricida, Inc.Employee Stock Option (right to buy)A Award	EVP, Clinical Development	AAward	+256K sh	—	—	256,000
2021-12-31	Tricida, Inc.F Tax Payment	EVP, Clinical Development	FTax Payment	−1,574 sh	$9.56	−$15K	3,465
2021-06-10	Tricida, Inc.Employee Stock Option (right to buy)A Award	EVP, Clinical Development	AAward	+125K sh	—	—	125,000
2021-01-17	Tricida, Inc.Common StockA Award	EVP, Clinical Development	AAward	+186K sh	—	—	186,000
2020-09-10	Tricida, Inc.A Award	EVP, Clinical Development	AAward	+4,000 sh	—	—	4,637
2020-05-08	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+210 sh	$1.68	+$352.8	465
2020-05-08	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−210 sh	$31.98	−$6,715.8	255
2020-05-08	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+830 sh	$1.68	+$1,394.4	1,085
2020-05-08	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−830 sh	$31.98	−$26.5K	255
2020-05-08	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+523 sh	$7.49	+$3,917.27	778
2020-05-08	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−523 sh	$31.98	−$16.7K	255
2020-05-08	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+1,437 sh	$2.39	+$3,434.43	1,692
2020-05-08	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−1,437 sh	$31.98	−$46K	255
2020-05-08	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−210 sh	—	—	420
2020-05-08	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−830 sh	—	—	4,190
2020-05-08	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−523 sh	—	—	23,033
2020-05-08	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−1,437 sh	—	—	15,386
2020-05-05	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+798 sh	$1.68	+$1,340.64	1,053
2020-05-05	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−798 sh	$30.05	−$24K	255
2020-05-05	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+452 sh	$2.39	+$1,080.28	707
2020-05-05	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−452 sh	$30.31	−$13.7K	255
2020-05-05	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−798 sh	—	—	5,020
2020-05-05	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−452 sh	—	—	16,823
2020-04-29	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+210 sh	$1.68	+$352.8	465
2020-04-29	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−210 sh	$31.98	−$6,715.8	255
2020-04-29	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+1,744 sh	$1.68	+$2,929.92	1,999
2020-04-29	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−1,744 sh	$31.98	−$55.8K	255
2020-04-29	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+523 sh	$2.39	+$1,249.97	778
2020-04-29	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−523 sh	$31.98	−$16.7K	255
2020-04-29	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+523 sh	$7.49	+$3,917.27	778
2020-04-29	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−523 sh	$31.98	−$16.7K	255
2020-04-29	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−210 sh	—	—	630
2020-04-29	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−1,744 sh	—	—	5,818
2020-04-29	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−523 sh	—	—	17,275
2020-04-29	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−523 sh	—	—	23,556
2020-04-28	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+1,250 sh	$1.68	+$2,100	1,505
2020-04-28	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−1,250 sh	$29.98	−$37.5K	255
2020-04-28	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−1,250 sh	—	—	7,562
2020-03-02	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+210 sh	$1.68	+$352.8	465
2020-03-02	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−210 sh	$31.98	−$6,715.8	255
2020-03-02	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+2,994 sh	$1.68	+$5,029.92	3,249
2020-03-02	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−2,994 sh	$31.78	−$95.1K	255
2020-03-02	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+523 sh	$2.39	+$1,249.97	778
2020-03-02	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−523 sh	$31.98	−$16.7K	255
2020-03-02	Tricida, Inc.M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+523 sh	$7.49	+$3,917.27	778
2020-03-02	Tricida, Inc.S Sale	EVP, Clinical Development	SSale	−523 sh	$31.98	−$16.7K	255
2020-03-02	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−210 sh	—	—	840
2020-03-02	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−2,994 sh	—	—	8,812
2020-03-02	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−523 sh	—	—	17,798
2020-03-02	Tricida, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−523 sh	—	—	24,079

Recent filings

Accepted (ET)
Mar 24
Otto Dawn Parsell0001595585-22-000016
SEC(opens sec.gov)
Jan 44
Otto Dawn Parsell0001595585-22-000004
SEC(opens sec.gov)
Jun 114
Otto Dawn Parsell0001595585-21-000075
SEC(opens sec.gov)
Jan 204
Otto Dawn Parsell0001595585-21-000024
SEC(opens sec.gov)
Sep 144
Otto Dawn Parsell0001595585-20-000126
SEC(opens sec.gov)
May 124
Otto Dawn Parsell0001595585-20-000068
SEC(opens sec.gov)
May 74
Otto Dawn Parsell0001595585-20-000064
SEC(opens sec.gov)

Companies

Tricida, Inc.EVP, Clinical Development

Address

7000 SHORELINE COURT, SUITE 201

SOUTH SAN FRANCISCO, CA, 94080